Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Ther Drug Monit. 2023 Mar 21;45(4):508–518. doi: 10.1097/FTD.0000000000001059

Table 1.

Participant demographics and characteristics

Quantitative strand Total (N = 138)
Clinical role
 Attending physician 53 (38)
 Pharmacist 45 (33)
 In-training physician (fellow) 20 (15)
 Advanced practice provider (nurse practitioner/physician’s assistant) 19 (14)
 Other 1 (1)
Years of experiencea
 0 years (still in training) 19 (15)
 1 to 5 years 39 (31)
 6 to 10 years 24 (19)
 11 to 20 years 32 (25)
 Greater than 20 years 14 (11)
Practice environmenta, b
 Critical care 90 (71)
 Infectious diseases 26 (21)
 Other 10 (8)
Average daily censusa
 0 to 5 patients 8 (6)
 6 to 10 patients 21 (17)
 11 to 15 patients 53 (42)
 16 to 20 patients 15 (12)
 21 to 25 patients 11 (9)
 26 to 30 patients 5 (4)
 Greater than 30 patients 13 (10)
Qualitative strand Total (N = 30)
Clinical role
 Attending physician 7 (23)
 Pharmacist 12 (40)
 In training physician 1 (3)
 Advanced practice provider (nurse practitioner/physician’s assistant) 4 (13)
 Bedside nurse 4 (13)
 Laboratory personnel 2 (7)
Practice environment
 Critical care 26 (87)
 Infectious diseases 2 (7)
 Other 2 (7)
Sex
 Woman 15 (50)
 Man 15 (50)
Career stage
 Early (<5 years from terminal training) 7 (23)
 Middle (5–15 years from terminal training) 9 (30)
 Late (>15 years from terminal training) 14 (47)
a:

Data available for 126 of 138 respondents, which is the denominator for calculated percentages

b:

Survey was distributed to 544 individuals affiliated with critical care and 89 affiliated with infectious diseases